stableImportance 4/5Confidence 5/51 documented update

The hydroxychloroquine rush turns official, and that is already a problem

The FDA gave emergency authorization to hydroxychloroquine and chloroquine for certain hospitalized COVID-19 patients, giving Trump a shiny object he had already been hyping way past the evidence. What looked like a tactical move in the moment immediately risked becoming a national case study in politics overrunning public health.

Why it matters: Drug gamble

First recorded Mar 28, 2020·Meaningfully updated Mar 28, 2020

Returning reader

Current status

No later development has been recorded. This evolving page currently contains the original verified report.

Complete record

Timeline

Newest first

Confidence 5/5

The hydroxychloroquine rush turns official, and that is already a problem

The FDA gave emergency authorization to hydroxychloroquine and chloroquine for certain hospitalized COVID-19 patients, giving Trump a shiny object he had already been hyping way past the evidence. What looked like a tactical move in the moment immediately risked becoming a national case study in politics overrunning public health.

Truth standard

What TDF can prove

The linked reports preserve their sources, audit notes, confidence rating, corrections, and comments. The page Q&A is restricted to those connected materials and will say when the evidence does not establish an answer.